TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22947271

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation for patients with mesorectal nodes >7 mm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treat all patients with preoperative chemoradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation for patients with mesorectal nodes >3 mm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No preoperative treatment
Number of subjects: 0
Study: 22134883

Group type: EXPERIMENTAL
Intervention: Listening to music during warm-up
Number of subjects: 12

Group type: COMPARATOR
Intervention: No music during warm-up
Number of subjects: 12
Study: 19156705

Group type: EXPERIMENTAL
Intervention: LM + Met
Number of subjects: 0

Group type: COMPARATOR
Intervention: G + Met
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confirmed hypoglycaemia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HbA(1c)
Number of subjects: 0
Study: 17178796

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 1.0 mg
Number of subjects: 192
Study: 15083366

Group type: EXPERIMENTAL
Intervention: Air Ventilation (AV) at 3 m s(‐1)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No Air Ventilation (NAV)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Air Ventilation (AV)
Number of subjects: 14
Study: 11786772

Group type: EXPERIMENTAL
Intervention: Ropivacaine (40 ml of 0.75 percent)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Isotonic saline infiltration
Number of subjects: 34
Study: 9844260

Group type: EXPERIMENTAL
Intervention: Interactive computer classroom (ICC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lecture/discussion format (LD)
Number of subjects: 0
Study: 7986518

Group type: EXPERIMENTAL
Intervention: Sublingual clonidine 0.3 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral clonidine 0.3 mg
Number of subjects: 10
Study: 2493098

Group type: EXPERIMENTAL
Intervention: 20 mg mitomycin C with 200,000 units hyaluronidase
Number of subjects: 28

Group type: COMPARATOR
Intervention: 20 mg mitomycin C alone
Number of subjects: 28
Study: 241454

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31617059

Group type: EXPERIMENTAL
Intervention: EQ‐5D‐5L index values
Number of subjects: 1215

Group type: EXPERIMENTAL
Intervention: Sex, age, cohabitation, social support
Number of subjects: 1215

Group type: EXPERIMENTAL
Intervention: Depression/anxiety
Number of subjects: 1215
Study: 30300020

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) therapy, 4 sessions of 29J/cm2 at 3 weekly intervals
Number of subjects: 28

Group type: COMPARATOR
Intervention: Silicone gel sheet (SGS), applied over the other half of the scar and changed at 3 weekly intervals
Number of subjects: 28
Study: 29364096

Group type: EXPERIMENTAL
Intervention: Levofloxacin containing sequential therapy with bismuth
Number of subjects: 190

Group type: COMPARATOR
Intervention: Levofloxacin containing sequential therapy
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 190
Study: 25626448

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin piperaquine (DHAP)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) vs Artesunate-amodiaquine (ASAQ)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) vs Dihydroartemisinin piperaquine (DHAP)
Number of subjects: 720
Study: 23099620

Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg twice daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg twice daily) + Itraconazole (200 mg once daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 20157716

Group type: EXPERIMENTAL
Intervention: Radiochemotherapy (RTCT)
Number of subjects: 3517

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 3517
Study: 20225473

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Clearfil SE Bond: SE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total-etch adhesive (Single Bond 2: SB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Collagenase solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Esterase solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phosphate buffer solution
Number of subjects: 0
Study: 16825003

Group type: EXPERIMENTAL
Intervention: Discretionary use of contrast media
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard echocardiography without contrast media
Number of subjects: 0
Study: 12899644

Group type: EXPERIMENTAL
Intervention: Basiliximab 20mg intravenously on days 0 and 4
Number of subjects: 1185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1185
Study: 10657767

Group type: EXPERIMENTAL
Intervention: Broad spectrum herbal therapy ointment (BSHT) at 1% v/v
Number of subjects: 50
Study: 9088399

Group type: EXPERIMENTAL
Intervention: Bendazac lysine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8478306

Group type: EXPERIMENTAL
Intervention: Dirithromycin (500 mg once daily for 5-7 days)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Miocamycin (600 mg twice daily for 5-7 days)
Number of subjects: 161
Study: 3021498

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium, 4 mg four times daily
Number of subjects: 54
Study: 31648928

Group type: EXPERIMENTAL
Intervention: Project UPLIFT
Number of subjects: 107

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 107
Study: 29996476

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (400 mg of magnesium oxide daily)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 59
Study: 27613505

Group type: EXPERIMENTAL
Intervention: Varenicline (0.5mg BID × 5 doses)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 24502384

Group type: EXPERIMENTAL
Intervention: Everolimus (CNI-free regimen)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Modification of Diet in Renal Disease (four-variable)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Nankivell
Number of subjects: 81

Group type: COMPARATOR
Intervention: CNI-based regimen
Number of subjects: 81

Group type: COMPARATOR
Intervention: CNI-free patients
Number of subjects: 81

Group type: COMPARATOR
Intervention: CNI patients
Number of subjects: 81
Study: 22261780

Group type: EXPERIMENTAL
Intervention: Modified thresholding
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Modified fuzzy C-means
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Modified normalized cut method
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Preprocessing and postprocessing
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Modified methods using textural energy and Hounsfield value
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 41
Study: 20347363

Group type: EXPERIMENTAL
Intervention: Damping factor measurement in patients with vertebral fractures
Number of subjects: 67

Group type: COMPARATOR
Intervention: Damping factor measurement in patients without vertebral fractures
Number of subjects: 67
Study: 17547877

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 177
Study: 16075984

Group type: EXPERIMENTAL
Intervention: BCG polysaccharides nucleic acid plus ketotefen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketotefen
Number of subjects: 60
Study: 12270988

Group type: EXPERIMENTAL
Intervention: Mupirocin (thrice-weekly application)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no ointment)
Number of subjects: 50
Study: 9883435

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Etretinate
Number of subjects: 31
Study: 8564652

Group type: EXPERIMENTAL
Intervention: Propacetamol on demand (D Group)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Propacetamol systematically (S Group)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both groups (D Group and S Group)
Number of subjects: 119
Study: 2195734

Group type: EXPERIMENTAL
Intervention: cyclosporin (Cs) treatment for one year
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: cyclosporin (Cs) treatment for three months
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: cyclosporin (Cs) treatment for twelve months
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: cyclosporin (Cs) treatment
Number of subjects: 188

Group type: COMPARATOR
Intervention: placebo treatment
Number of subjects: 188
Study: 154624

Group type: EXPERIMENTAL
Intervention: Arecoline (cholinergic agonist)
Number of subjects: 6
Study: 31195828

Group type: EXPERIMENTAL
Intervention: 1-day Acceptance and Commitment Therapy workshop
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: PROMIS Anxiety Short Form 8a
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: PROMIS Depression Short Form 8b
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: PROMIS Pain Interference Short Form 8a
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: PROMIS Anxiety Short Form 8a and PROMIS Depression Short Form 8b
Number of subjects: 67
Study: 30679036

Group type: EXPERIMENTAL
Intervention: RYGB
Number of subjects: 100

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 100
Study: 28158981

Group type: EXPERIMENTAL
Intervention: Improved clinical service delivery through the BHOMA trial in 46 clinics
Number of subjects: 318380

Group type: EXPERIMENTAL
Intervention: Antihypertensive medication availability
Number of subjects: 318380

Group type: EXPERIMENTAL
Intervention: Monitoring hypertension process indicators
Number of subjects: 318380

Group type: EXPERIMENTAL
Intervention: Patient visit attendance
Number of subjects: 318380

Group type: EXPERIMENTAL
Intervention: Chart recorded hypertension diagnosis
Number of subjects: 318380
Study: 26232911

Group type: EXPERIMENTAL
Intervention: 250 g of low-fat lamb per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: 250 g of high-fat lamb per day
Number of subjects: 20
Study: 23957603

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Ecologic 825, Winclove, Amsterdam, the Netherlands) for 8 weeks after 4 weeks of antibiotics
Number of subjects: 16

Group type: COMPARATOR
Intervention: Active pouchitis
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Antibiotics or probiotics
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy pouch (control)
Number of subjects: 16
Study: 21427431

Group type: EXPERIMENTAL
Intervention: Modafinil/Armodafinil
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 18955523

Group type: EXPERIMENTAL
Intervention: OPT-80
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study: 15863861

Group type: EXPERIMENTAL
Intervention: 0.1% adapalene gel
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide lotion
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Combination of 0.1% adapalene gel + 5% benzoyl peroxide
Number of subjects: 105
Study: 12423709

Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg
Number of subjects: 892

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 892
Study: 10716064

Group type: EXPERIMENTAL
Intervention: Tiludronate 400 mg
Number of subjects: 153

Group type: COMPARATOR
Intervention: Pilot model development data set
Number of subjects: 153
Study: 7793555

Group type: EXPERIMENTAL
Intervention: Physostigmine/glycopyrronium mixture
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 28
Study: 1954639

Group type: EXPERIMENTAL
Intervention: Ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ginseng extract
Number of subjects: 50
Study: 7447218

Group type: EXPERIMENTAL
Intervention: 1 g of methylprednisolone, intravenously, once a month for 6 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30554073

Group type: EXPERIMENTAL
Intervention: Cetuximab plus FOLFIRI
Number of subjects: 491

Group type: COMPARATOR
Intervention: Bevacizumab plus FOLFIRI
Number of subjects: 491
Study: 27465403

Group type: EXPERIMENTAL
Intervention: Web conferencing or telephones connecting caregivers with hospice care team during care plan meetings
Number of subjects: 446

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 446
Study: 25912520

Group type: EXPERIMENTAL
Intervention: Quest to Lava Mountain (QTLM) computer game, implemented for 90 min/week for 6 weeks
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Higher QTLM exposure and gaming progress
Number of subjects: 94

Group type: COMPARATOR
Intervention: Comparison group (no QTLM exposure)
Number of subjects: 94
Study: 24608310

Group type: EXPERIMENTAL
Intervention: Sodium picosulfate with a prepackaged low-residue diet
Number of subjects: 194

Group type: COMPARATOR
Intervention: 4-L PEG solution
Number of subjects: 194
Study: 22859343

Group type: EXPERIMENTAL
Intervention: Incentive spirometer exercise (ISE) plus conventional exercise (CE); n=23
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional exercise (CE) alone; n=23
Number of subjects: 46
Study: 19958854

Group type: EXPERIMENTAL
Intervention: Dalcetrapib 600 mg daily
Number of subjects: 15600

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 15600
Study: 17716288

Group type: EXPERIMENTAL
Intervention: Lipo Cream
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lipo Milk
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lipo Ointment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 15207957

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 5006

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 5006

Group type: EXPERIMENTAL
Intervention: Both Valsartan and Amlodipine
Number of subjects: 5006
Study: 11756949

Group type: EXPERIMENTAL
Intervention: Tacrolimus (FK506) 0.1% ointment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 0.1% ointment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study: 9520627

Group type: EXPERIMENTAL
Intervention: Active clinical rehabilitation involving systematic perturbation of sitting posture using submaximal reaching movements over four reaching distances.
Number of subjects: 2
Study: 8083390

Group type: EXPERIMENTAL
Intervention: Inflight exercise (experimental)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Restricted activity (control)
Number of subjects: 78
Study: 2683189

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 611

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 611
Study: 956798

Group type: EXPERIMENTAL
Intervention: Therapist self-reported behavioral arousal during therapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Physiological activation during therapy (measured by electromyogram, heart rate, blood pressure, skin conductance)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Difficulty of the patient (easy vs difficult-to-interview)
Number of subjects: 18
Study: 31008776

Group type: EXPERIMENTAL
Intervention: Decision aid intervention plus standard care
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 30
Study: 31721936

Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Strength Training combined with Electrical Muscle Stimulation (ST+EMS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Untrained Control (UN)
Number of subjects: 58
Study: 27868384

Group type: EXPERIMENTAL
Intervention: Post-acute group exercise program
Number of subjects: 422

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 422
Study: 26608727

Group type: EXPERIMENTAL
Intervention: Direct access to low-dose computed tomography (LDCT) from primary care combined with a 1 h lung cancer update meeting.
Number of subjects: 331

Group type: COMPARATOR
Intervention: Control group (standard care without direct access to LDCT).
Number of subjects: 331
Study: 22761006

Group type: EXPERIMENTAL
Intervention: Trans-dermal nicotine patches and cognitive behavioral therapy (Group 1)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy alone (Group 2)
Number of subjects: 52
Study: 22165113

Group type: EXPERIMENTAL
Intervention: Ni‐Cr alloy PFM crown
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Co‐Cr alloy PFM crown
Number of subjects: 30

Group type: COMPARATOR
Intervention: Au‐Pt alloy PFM crown
Number of subjects: 30
Study: 18322027

Group type: EXPERIMENTAL
Intervention: DESMOND education sessions
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study: 16801465

Group type: EXPERIMENTAL
Intervention: Trandolapril (target, 4 mg/d)
Number of subjects: 8290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8290
Study: 12732391

Group type: EXPERIMENTAL
Intervention: Unopposed 17beta-estradiol administered for a 2-year treatment period
Number of subjects: 199
Study: 10819344

Group type: EXPERIMENTAL
Intervention: Cefpodoxime-proxetil, 8 mg/kg/day in two divided doses for 5 days followed by 5 days of placebo
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Cefpodoxime-proxetil, 8 mg/kg/day in two divided doses for 10 days
Number of subjects: 450
Study: 9082341

Group type: EXPERIMENTAL
Intervention: CAPD treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (40 healthy young male volunteers)
Number of subjects: 10
Study: 1797696

Group type: EXPERIMENTAL
Intervention: 10 mg carteolol/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6683554

Group type: COMPARATOR
Intervention: Bifonazole cream 1%, solution 1%, gel 1%, and powder 1% administered once daily for 2 or 3 weeks
Number of subjects: 1129
Study: 31419271

Group type: EXPERIMENTAL
Intervention: Spironolactone 25mg per day for 12 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no spironolactone)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Spironolactone group
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 29228436

Group type: EXPERIMENTAL
Intervention: Atomized inhalation of ipratropium bromide and budesonide suspension, oxygen flow 3-5 L/min, 15-20 min/time, twice a day for 1 week
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group received routine treatment including saline through a ventilator mask
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Atomized inhalation of ipratropium bromide and budesonide suspension
Number of subjects: 86
Study: 26435087

Group type: EXPERIMENTAL
Intervention: InterX5000 treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Baseline comparison with asymptomatic subjects
Number of subjects: 25
Study: 24354496

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day for 4 weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day for 4 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy control group (no treatment)
Number of subjects: 16
Study: 22933498

Group type: EXPERIMENTAL
Intervention: Corticosteroid
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 19476406

Group type: EXPERIMENTAL
Intervention: Brimonidine-timolol (BID) as monotherapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Dorzolamide-timolol (BID) as monotherapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Brimonidine-timolol (BID) as adjunctive therapy to PGA
Number of subjects: 180

Group type: COMPARATOR
Intervention: Dorzolamide-timolol (BID) as adjunctive therapy to PGA
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Brimonidine-timolol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Dorzolamide-timolol
Number of subjects: 180
Study: 17890171

Group type: EXPERIMENTAL
Intervention: Blood pressure lowering with perindopril/indapamide combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive glucose control using gliclazide MR based regimen
Number of subjects: 0
Study: 15337535

Group type: EXPERIMENTAL
Intervention: 8 months of flutamide and goserelin before RT
Number of subjects: 378

Group type: COMPARATOR
Intervention: 3 months of flutamide and goserelin before RT
Number of subjects: 378
Study: 11136837

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 13388

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13388
Study: 11742422

Group type: EXPERIMENTAL
Intervention: Group-oriented reconditioning programme (3-4 weeks, 3-7 hours of walks in hilly ground three times a week)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Standard programme with a mix of passive and active elements
Number of subjects: 173
Study: 9313005

Group type: COMPARATOR
Intervention: Antileukotrienes
Number of subjects: 0
Study: 8120830

Group type: EXPERIMENTAL
Intervention: Running with normal arm movements
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Running without arm movements
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Running with breathing paced by an acoustic signal
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Running with high degree of co-ordination
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cycling
Number of subjects: 34
Study: 3551645

Group type: EXPERIMENTAL
Intervention: Closed-suction drains (Group I)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Penrose drains (Group II)
Number of subjects: 128
Study: 28158582

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 232

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 232
Study: 26855107

Group type: EXPERIMENTAL
Intervention: Levonorgestrel contraceptive implant (150 mg), initiated immediately
Number of subjects: 414

Group type: COMPARATOR
Intervention: Control group (3-month delay in implant initiation)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Levonorgestrel contraceptive implant (150 mg)
Number of subjects: 414